Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06VSA
|
|||
| Former ID |
DNC013995
|
|||
| Drug Name |
Methyl 2-(7-phenylheptanoyl)oxazole-5-carboxylate
|
|||
| Synonyms |
CHEMBL220784; methyl 2-(7-phenylheptanoyl)oxazole-5-carboxylate; SCHEMBL3140826; Methyl 2-(7-phenylheptanoyl)-1,3-oxazole-5-carboxylate; BIKPWTFTYRRSPI-UHFFFAOYSA-N
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H21NO4
|
|||
| Canonical SMILES |
COC(=O)C1=CN=C(O1)C(=O)CCCCCCC2=CC=CC=C2
|
|||
| InChI |
1S/C18H21NO4/c1-22-18(21)16-13-19-17(23-16)15(20)12-8-3-2-5-9-14-10-6-4-7-11-14/h4,6-7,10-11,13H,2-3,5,8-9,12H2,1H3
|
|||
| InChIKey |
BIKPWTFTYRRSPI-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase. J Med Chem. 2008 Aug 14;51(15):4392-403. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.